tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PSTV Stock Latest News

Plus Therapeutics’ ARISE Study: A New Hope for Fertility Treatment
Company AnnouncementsPlus Therapeutics’ ARISE Study: A New Hope for Fertility Treatment
3d ago
PSTV
Plus Therapeutics Signs Lease Agreement in Houston
PremiumCompany Announcements
Plus Therapeutics Signs Lease Agreement in Houston
10d ago
8K
PSTV
Plus Therapeutics provides update on CNSide Diagnostic platform launch
PremiumThe Fly
Plus Therapeutics provides update on CNSide Diagnostic platform launch
10d ago
PSTV
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PSTV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
17d ago
PSTV
Buy Rating for Plus Therapeutics Driven by Strategic Advancements and Market Expansion for CNSide Test
PremiumRatings
Buy Rating for Plus Therapeutics Driven by Strategic Advancements and Market Expansion for CNSide Test
1M ago
PSTV
Buy Rating for Plus Therapeutics Driven by CNSide Coverage and Promising Pipeline Developments
PremiumRatingsBuy Rating for Plus Therapeutics Driven by CNSide Coverage and Promising Pipeline Developments
1M ago
PSTV
Plus Therapeutics announces national coverage agreement with UnitedHealthcare
Premium
The Fly
Plus Therapeutics announces national coverage agreement with UnitedHealthcare
1M ago
UNH
PSTV
Plus Therapeutics announces $1.9M advance payment from CPRIT
Premium
The Fly
Plus Therapeutics announces $1.9M advance payment from CPRIT
1M ago
PSTV
Plus Therapeutics announces accreditation, certification for CNSide Diagnostics
PremiumThe Fly
Plus Therapeutics announces accreditation, certification for CNSide Diagnostics
1M ago
PSTV
Plus Therapeutics upgraded to Buy from Hold at D. Boral Capital
PremiumThe Fly
Plus Therapeutics upgraded to Buy from Hold at D. Boral Capital
2M ago
PSTV
Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
PremiumThe Fly
Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
2M ago
PSTV
Plus Therapeutics Secures Nasdaq Compliance Extension
PremiumCompany Announcements
Plus Therapeutics Secures Nasdaq Compliance Extension
2M ago
8K
PSTV
Plus Therapeutics price target lowered to $3 from $4 at Maxim
PremiumThe FlyPlus Therapeutics price target lowered to $3 from $4 at Maxim
2M ago
PSTV
Plus Therapeutics presents results from ReSPECT-LM Phase 1 trial
Premium
The Fly
Plus Therapeutics presents results from ReSPECT-LM Phase 1 trial
2M ago
PSTV
Optimistic Buy Rating for Plus Therapeutics Driven by Strategic Financial Positioning and Clinical Advancements
Premium
Ratings
Optimistic Buy Rating for Plus Therapeutics Driven by Strategic Financial Positioning and Clinical Advancements
3M ago
PSTV
Plus Therapeutics reports stockholders’ equity in excess of $2.5M
PremiumThe Fly
Plus Therapeutics reports stockholders’ equity in excess of $2.5M
3M ago
PSTV
Buy Rating for Plus Therapeutics: Strategic Market Launch and Promising Financial Outlook
PremiumRatings
Buy Rating for Plus Therapeutics: Strategic Market Launch and Promising Financial Outlook
3M ago
PSTV
Plus Therapeutics Reports Strong Q2 2025 Results
PremiumCompany Announcements
Plus Therapeutics Reports Strong Q2 2025 Results
3M ago
PSTV
Plus Therapeutics Awaits Nasdaq Compliance Confirmation
PremiumCompany Announcements
Plus Therapeutics Awaits Nasdaq Compliance Confirmation
3M ago
8K
PSTV
Plus Therapeutics presents data from analysis of CNSide CSF Assay
PremiumThe FlyPlus Therapeutics presents data from analysis of CNSide CSF Assay
3M ago
PSTV
Plus Therapeutics Granted Continued Nasdaq Listing
Premium
Company Announcements
Plus Therapeutics Granted Continued Nasdaq Listing
3M ago
8K
PSTV
Plus Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Plus Therapeutics Approves Key Proposals at Annual Meeting
3M ago
8K
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >